Syntekabio to Showcase Innovative AI Drug Discovery Technologies at Bio-IT World
April 11, 2024 10:15 ET
|
Syntekabio USA Inc.
NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) -- Syntekabio (226330.KQ), a global artificial intelligence (AI) drug discovery pioneer, today announced its participation at the upcoming Bio-IT World...
Understanding Pharmacovigilance Regulations in Asia-Pacific Training Course (Online Event, July 8-9, 2024)
April 04, 2024 07:47 ET
|
Research and Markets
Dublin, April 04, 2024 (GLOBE NEWSWIRE) -- The "Understanding Pharmacovigilance Regulations in APAC Training Course" conference has been added to ResearchAndMarkets.com's offering. ...
Pattern to Participate in Life Science Innovation Northwest 2024 Conference
April 03, 2024 16:55 ET
|
PATTERN COMPUTER, INC.
REDMOND, Wash., April 03, 2024 (GLOBE NEWSWIRE) -- Pattern Computer®, Inc. (“Pattern” or “the Company”) today announced that Mark R. Anderson, Chairman and CEO, Matt Keener, CTO, and Nidhi Singh,...
Contract Research Organization Services (CROs) Global Strategic Research Report 2024: Market to Reach $149.1 Billion by 2030 - CROs to Leverage Artificial Intelligence in a Major Way
April 03, 2024 07:52 ET
|
Research and Markets
Dublin, April 03, 2024 (GLOBE NEWSWIRE) -- The "Contract Research Organization Services (CROs) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global...
Global Recombinant Proteins Market Report - Growth Factors & Chemokines Segment to Dominate Market During Forecast Period 2024-2028
April 02, 2024 11:52 ET
|
Research and Markets
Dublin, April 02, 2024 (GLOBE NEWSWIRE) -- The "Global Recombinant Proteins Market by Product (Growth Factors, Chemokines, Structural Proteins, Membrane Proteins), Application (Drug Discovery &...
Global Active Pharmaceutical Ingredient CDMO Market Projected to Reach USD 164.5 Billion by 2030
March 29, 2024 05:36 ET
|
Research and Markets
Dublin, March 29, 2024 (GLOBE NEWSWIRE) -- The "Active Pharmaceutical Ingredient CDMO Market Size, Share & Trends Analysis Report By Product, By Synthesis, By Drug, By Application, By Workflow,...
Larkspur Biosciences to Present New Preclinical Research on Lead Development Program Candidate, a First-in-Class PIP4K2C Protein Degrader, at AACR 2024
March 28, 2024 08:00 ET
|
Larkspur Biosciences, Inc.
Larkspur Biosciences to Present New Preclinical Research on Lead Development Program Candidate, a First-in-Class PIP4K2C Protein Degrader, at AACR 2024
CHARM Therapeutics Announces Foundation of Scientific Advisory Board (SAB)
March 19, 2024 10:00 ET
|
Charm Therapeutics
PRESS RELEASE CHARM Therapeutics Announces Foundation of Scientific Advisory Board (SAB) LONDON – 19 March 2024 -- CHARM Therapeutics (“CHARM”, “The Company”), a 3D deep-learning research company...
UPDATE – Pattern to Present at 23rd Annual Needham Virtual Healthcare Conference
March 18, 2024 10:30 ET
|
PATTERN COMPUTER, INC.
REDMOND, Wash., March 18, 2024 (GLOBE NEWSWIRE) -- Pattern Computer®, Inc. (“Pattern” or “the Company”) today announced that Mark R. Anderson, Chairman and CEO, will participate in the 23rd Annual...
Pattern to Present at 23rd Annual Needham Virtual Healthcare Conference
March 18, 2024 08:30 ET
|
PATTERN COMPUTER, INC.
REDMOND, Wash., March 18, 2024 (GLOBE NEWSWIRE) -- Pattern Computer®, Inc. (“Pattern” or “the Company”) today announced that Mark R. Anderson, Chairman and CEO, will participate in the 23rd Annual...